A PHASE-I STUDY OF MTA (MULTITARGETED ANTIFOLATE, LY231514) PLUS CISPLATIN (CIS) IN PATIENTS WITH ADVANCED SOLID TUMORS

Citation
R. Thoedtmann et al., A PHASE-I STUDY OF MTA (MULTITARGETED ANTIFOLATE, LY231514) PLUS CISPLATIN (CIS) IN PATIENTS WITH ADVANCED SOLID TUMORS, European journal of cancer, 33, 1997, pp. 1116-1116
Citations number
NO
Categorie Soggetti
Oncology
Journal title
ISSN journal
09598049
Volume
33
Year of publication
1997
Supplement
8
Pages
1116 - 1116
Database
ISI
SICI code
0959-8049(1997)33:<1116:APSOM(>2.0.ZU;2-5